T cell receptor (TCR) gene therapy to treat melanoma: lessons from clinical and preclinical studies (Q33530527)

27 July 2017

1 reference

title

T cell receptor (TCR) gene therapy to treat melanoma: lessons from clinical and preclinical studies (English)

1 reference

27 July 2017

0 references

Coen Govers

3

0 references

Reno Debets

6

object named as

Reno Debets

1 reference

27 July 2017

Miriam Coccoris

1

1 reference

27 July 2017

Trudy Straetemans

2

1 reference

27 July 2017

Cor Lamers

4

1 reference

27 July 2017

Stefan Sleijfer

5

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

Expert Opinion on Biological Therapy

27 July 2017

1 reference

27 July 2017

10

1 reference

27 July 2017

4

1 reference

27 July 2017

547-562

1 reference

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

27 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Adoptive cell therapy for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Human T cell responses against melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Transfer of specificity by murine alpha and beta T-cell receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Cancer regression in patients after transfer of genetically engineered lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Antigen choice in adoptive T-cell therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

About human tumor antigens to be used in immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Unique human tumor antigens: immunobiology and use in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Transduction of an HLA-DP4-restricted NY-ESO-1-specific TCR into primary human CD4+ lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Cancer testis antigens in human melanoma stem cells: expression, distribution, and methylation status

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

T cell defined tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Functional analysis of tumor-specific Th cell responses detected in melanoma patients after dendritic cell-based immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Phoenix-ampho outperforms PG13 as retroviral packaging cells to transduce human T cells with tumor-specific receptors: implications for clinical immunogene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Lentiviral vector design for optimal T cell receptor gene expression in the transduction of peripheral blood lymphocytes and tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Retroviral vectors for high-level transgene expression in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Use of the 2A sequence from foot-and-mouth disease virus in the generation of retroviral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Retroviral vector-mediated expression of HoxB4 in hematopoietic cells using a novel coexpression strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Resistance of mature T cells to oncogene transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Codon usage limitation in the expression of HIV-1 envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Selecting highly affine and well-expressed TCRs for gene therapy of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Codon modification of T cell receptors allows enhanced functional expression in transgenic human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Redirection of T cells by delivering a transgenic mouse-derived MDM2 tumor antigen-specific TCR and its humanized derivative is governed by the CD8 coreceptor and affects natural human TCR expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Targeting the Wilms tumor antigen 1 by TCR gene transfer: TCR variants improve tetramer binding but not the function of gene modified human T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Stable, soluble T-cell receptor molecules for crystallization and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Facilitating matched pairing and expression of TCR chains introduced into human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Human TCR that incorporate CD3zeta induce highly preferred pairing between TCRalpha and beta chains following gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Flexible and sensitive method to functionally validate tumor-specific receptors via activation of NFAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Functional three-domain single-chain T-cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Can combined T-cell- and antibody-based immunotherapy outsmart tumor cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

The promise and potential pitfalls of chimeric antigen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Recombinant antibodies with T-cell receptor-like specificity: novel tools to study MHC class I presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Selection of human antibody fragments directed against tumor T-cell epitopes for adoptive T-cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

A phage display selected fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

An inducible caspase 9 safety switch can halt cell therapy-induced autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

An inducible caspase 9 safety switch for T-cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Characterization of CD20-transduced T lymphocytes as an alternative suicide gene therapy approach for the treatment of graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Changing T cell specificity by retroviral T cell receptor display

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

In vitro evolution of a T cell receptor with high affinity for peptide/MHC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Directed evolution of a stable scaffold for T-cell receptor engineering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

TCR-like human antibodies expressed on human CTLs mediate antibody affinity-dependent cytolytic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Increasing functional avidity of TCR-redirected T cells by removing defined N-glycosylation sites in the TCR constant domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Integrated src kinase and costimulatory activity enhances signal transduction through single-chain chimeric receptors in T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Transgenic TCR expression: comparison of single chain with full-length receptor constructs for T-cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFNgamma production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

T cell retargeting with MHC class I-restricted antibodies: the CD28 costimulatory domain enhances antigen-specific cytotoxicity and cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Costimulation tunes tumor-specific activation of redirected T cells in adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Lineage relationship and protective immunity of memory CD8 T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

IL-15 Promotes the Survival of Naive and Memory Phenotype CD8+ T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Primary human T lymphocytes engineered with a codon-optimized IL-15 gene resist cytokine withdrawal-induced apoptosis and persist long-term in the absence of exogenous cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Interleukin 21 therapy increases the density of tumor infiltrating CD8+ T cells and inhibits the growth of syngeneic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Safety and immunologic effects of IL-15 administration in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Interleukin-15/interleukin-15R alpha complexes promote destruction of established tumors by reviving tumor-resident CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Ex vivo expansion of tumor specific lymphocytes with IL-15 and IL-21 for adoptive immunotherapy in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Functional human antigen-specific T cells produced in vitro using retroviral T cell receptor transfer into hematopoietic progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Exhaustion of cytotoxic T cells during adoptive immunotherapy of virus carrier mice can be prevented by B cells or CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Tumor rejection by disturbing tumor stroma cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Generation and targeting of human tumor-specific Tc1 and Th1 cells transduced with a lentivirus containing a chimeric immunoglobulin T-cell receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Tumor-specific Th17-polarized cells eradicate large established melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

CD8 alpha coreceptor to improve TCR gene transfer to treat melanoma: down-regulation of tumor-specific production of IL-4, IL-5, and IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Alphabeta T-cell receptor engineered gammadelta T cells mediate effective antileukemic reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Alpha beta T cell receptor transfer to gamma delta T cells generates functional effector cells without mixed TCR dimers in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Nonmyeloablative immunosuppressive regimen prolongs In vivo persistence of gene-modified autologous T cells in a nonhuman primate model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Complete regression of advanced primary and metastatic mouse melanomas following combination chemoimmunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Injection of glycosylated recombinant simian IL-7 provokes rapid and massive T-cell homing in rhesus macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

TCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Combination of vaccination and chimeric receptor expressing T cells provides improved active therapy of tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Antitumor effects of HSV-TK engineered donor lymphocytes after allogeneic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

Context Dependence of Different Modules for Posttranscriptional Enhancement of Gene Expression from Retroviral Vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003614756

10.1517/14712591003614756

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference